nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—Benzphetamine—SLC18A2—type 1 diabetes mellitus	0.0293	0.458	CrCbGaD
Phenylbutazone—Diphenhydramine—CHRM2—type 1 diabetes mellitus	0.0112	0.175	CrCbGaD
Phenylbutazone—PTGIS—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.0111	0.0119	CbGpPWpGaD
Phenylbutazone—Fosphenytoin—ALB—type 1 diabetes mellitus	0.0111	0.173	CrCbGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CBLB—type 1 diabetes mellitus	0.0107	0.0114	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—CRP—type 1 diabetes mellitus	0.0107	0.0114	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—type 1 diabetes mellitus	0.01	0.0107	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC29A3—type 1 diabetes mellitus	0.00943	0.0101	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—type 1 diabetes mellitus	0.0092	0.00983	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—type 1 diabetes mellitus	0.00913	0.00975	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—G6PC2—type 1 diabetes mellitus	0.00898	0.00959	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—type 1 diabetes mellitus	0.00868	0.00928	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—E2F1—type 1 diabetes mellitus	0.00858	0.00917	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—CRP—type 1 diabetes mellitus	0.00847	0.00905	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—type 1 diabetes mellitus	0.00835	0.00892	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—type 1 diabetes mellitus	0.00768	0.00821	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—type 1 diabetes mellitus	0.00762	0.00814	CbGpPWpGaD
Phenylbutazone—Phenprocoumon—ALB—type 1 diabetes mellitus	0.00759	0.118	CrCbGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00753	0.00804	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—type 1 diabetes mellitus	0.00718	0.00768	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—type 1 diabetes mellitus	0.00699	0.00747	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—G6PC2—type 1 diabetes mellitus	0.00685	0.00731	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—type 1 diabetes mellitus	0.00668	0.00714	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—type 1 diabetes mellitus	0.0064	0.00684	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—INS—type 1 diabetes mellitus	0.00623	0.00666	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—IGF1—type 1 diabetes mellitus	0.00603	0.00644	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—HBA1—type 1 diabetes mellitus	0.00599	0.0064	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—type 1 diabetes mellitus	0.00597	0.00638	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC18A2—type 1 diabetes mellitus	0.00596	0.00637	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00574	0.00613	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—G6PC2—type 1 diabetes mellitus	0.00571	0.0061	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PRKCQ—type 1 diabetes mellitus	0.00559	0.00598	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—CP—type 1 diabetes mellitus	0.00548	0.00586	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—type 1 diabetes mellitus	0.00544	0.00581	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP12—type 1 diabetes mellitus	0.005	0.00534	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL1R1—type 1 diabetes mellitus	0.00496	0.0053	CbGpPWpGaD
Phenylbutazone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—type 1 diabetes mellitus	0.00494	0.00528	CbGpPWpGaD
Phenylbutazone—Phenytoin—ALB—type 1 diabetes mellitus	0.00489	0.0763	CrCbGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—TNF—type 1 diabetes mellitus	0.00483	0.00516	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—E2F1—type 1 diabetes mellitus	0.00481	0.00514	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00479	0.00512	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—HBA1—type 1 diabetes mellitus	0.00475	0.00508	CbGpPWpGaD
Phenylbutazone—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—type 1 diabetes mellitus	0.00474	0.00506	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—type 1 diabetes mellitus	0.00465	0.00496	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.00456	0.00487	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC18A2—type 1 diabetes mellitus	0.00454	0.00485	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—type 1 diabetes mellitus	0.00452	0.00483	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—E2F1—type 1 diabetes mellitus	0.0045	0.0048	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.00435	0.00465	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—type 1 diabetes mellitus	0.00432	0.00462	CbGpPWpGaD
Phenylbutazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00431	0.0046	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—G6PC2—type 1 diabetes mellitus	0.00428	0.00457	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—type 1 diabetes mellitus	0.00422	0.00451	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—LGALS3—type 1 diabetes mellitus	0.00418	0.00447	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—CP—type 1 diabetes mellitus	0.00418	0.00447	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—type 1 diabetes mellitus	0.00415	0.00443	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—type 1 diabetes mellitus	0.00414	0.00442	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.00395	0.00423	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—CAT—type 1 diabetes mellitus	0.00394	0.00421	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—STAT3—type 1 diabetes mellitus	0.0039	0.00417	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—IL6—type 1 diabetes mellitus	0.0039	0.00417	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—TNF—type 1 diabetes mellitus	0.00383	0.0041	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—HBA2—type 1 diabetes mellitus	0.00381	0.00407	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC18A2—type 1 diabetes mellitus	0.00379	0.00405	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—type 1 diabetes mellitus	0.00375	0.00401	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—SOD2—type 1 diabetes mellitus	0.00374	0.00399	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—type 1 diabetes mellitus	0.00367	0.00392	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—G6PC2—type 1 diabetes mellitus	0.00358	0.00383	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—CP—type 1 diabetes mellitus	0.00349	0.00373	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.00348	0.00372	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—type 1 diabetes mellitus	0.00346	0.0037	CbGpPWpGaD
Phenylbutazone—PTGS1—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.00342	0.00365	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—IL1R1—type 1 diabetes mellitus	0.00338	0.00361	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—TNF—type 1 diabetes mellitus	0.00337	0.00361	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—CRP—type 1 diabetes mellitus	0.00313	0.00334	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—CAT—type 1 diabetes mellitus	0.00313	0.00334	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ABCC8—type 1 diabetes mellitus	0.0031	0.00332	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—IL6—type 1 diabetes mellitus	0.00309	0.00331	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.00303	0.00323	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.00302	0.00322	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—NOS1—type 1 diabetes mellitus	0.00301	0.00321	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—SOD2—type 1 diabetes mellitus	0.00297	0.00317	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.0029	0.0031	CbGpPWpGaD
Phenylbutazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00284	0.00303	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.00279	0.00298	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.00276	0.00295	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—type 1 diabetes mellitus	0.00273	0.00292	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CXCL10—type 1 diabetes mellitus	0.00273	0.00291	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—IL6—type 1 diabetes mellitus	0.00272	0.00291	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—INS—type 1 diabetes mellitus	0.00262	0.0028	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SLC11A1—type 1 diabetes mellitus	0.00259	0.00277	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.00254	0.00272	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.00252	0.00269	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—CRP—type 1 diabetes mellitus	0.00249	0.00266	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—ITPR3—type 1 diabetes mellitus	0.00247	0.00264	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—KCNJ11—type 1 diabetes mellitus	0.00245	0.00262	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—type 1 diabetes mellitus	0.00243	0.0026	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—type 1 diabetes mellitus	0.00243	0.00259	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—ALB—type 1 diabetes mellitus	0.0024	0.00256	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—APOC3—type 1 diabetes mellitus	0.00231	0.00247	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IAPP—type 1 diabetes mellitus	0.00231	0.00247	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.00231	0.00247	CbGpPWpGaD
Phenylbutazone—CYP3A4—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.0023	0.00245	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL4—type 1 diabetes mellitus	0.00227	0.00243	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—E2F1—type 1 diabetes mellitus	0.00226	0.00242	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—B2M—type 1 diabetes mellitus	0.00222	0.00237	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IFNG—type 1 diabetes mellitus	0.00219	0.00234	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.00213	0.00227	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.00211	0.00225	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—INS—type 1 diabetes mellitus	0.00208	0.00222	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ITPR3—type 1 diabetes mellitus	0.00207	0.00221	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.00198	0.00212	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	0.00196	0.00209	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IL1B—type 1 diabetes mellitus	0.00195	0.00209	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—HBA1—type 1 diabetes mellitus	0.00195	0.00208	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—APOC3—type 1 diabetes mellitus	0.00194	0.00207	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.00193	0.00206	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—ALB—type 1 diabetes mellitus	0.0019	0.00204	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—GSTT1—type 1 diabetes mellitus	0.0019	0.00203	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	0.00189	0.00202	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NOS1—type 1 diabetes mellitus	0.00186	0.00199	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CDK4—type 1 diabetes mellitus	0.00184	0.00197	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.0018	0.00192	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—NOS2—type 1 diabetes mellitus	0.00179	0.00191	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.00177	0.00189	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—type 1 diabetes mellitus	0.00177	0.00189	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.00176	0.00188	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.00175	0.00187	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PRKCQ—type 1 diabetes mellitus	0.00174	0.00186	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CD4—type 1 diabetes mellitus	0.00174	0.00186	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IFNG—type 1 diabetes mellitus	0.00174	0.00186	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—VAV1—type 1 diabetes mellitus	0.00169	0.00181	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IL1B—type 1 diabetes mellitus	0.00155	0.00166	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.00154	0.00164	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—GCG—type 1 diabetes mellitus	0.00152	0.00162	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	0.00149	0.0016	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.00148	0.00158	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CD86—type 1 diabetes mellitus	0.00148	0.00158	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—TNF—type 1 diabetes mellitus	0.00142	0.00151	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IFNG—type 1 diabetes mellitus	0.00137	0.00147	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.00134	0.00143	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—ERBB3—type 1 diabetes mellitus	0.00133	0.00142	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CCR5—type 1 diabetes mellitus	0.00131	0.0014	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CAT—type 1 diabetes mellitus	0.00128	0.00137	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—HLA-A—type 1 diabetes mellitus	0.00128	0.00136	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.00125	0.00134	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	0.00125	0.00133	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL1B—type 1 diabetes mellitus	0.00123	0.00131	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CASP3—type 1 diabetes mellitus	0.00122	0.00131	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL2—type 1 diabetes mellitus	0.00122	0.00131	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.00119	0.00127	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—HBA2—type 1 diabetes mellitus	0.00117	0.00125	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	0.00114	0.00122	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—TNF—type 1 diabetes mellitus	0.00113	0.0012	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NOS2—type 1 diabetes mellitus	0.00111	0.00119	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—G6PC2—type 1 diabetes mellitus	0.0011	0.00118	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.00108	0.00116	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CD80—type 1 diabetes mellitus	0.00108	0.00115	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.00106	0.00113	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—G6PC2—type 1 diabetes mellitus	0.00104	0.00111	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—INS—type 1 diabetes mellitus	0.00102	0.00109	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000995	0.00106	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000954	0.00102	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—EGFR—type 1 diabetes mellitus	0.000934	0.000998	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HBA2—type 1 diabetes mellitus	0.000929	0.000993	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—TYK2—type 1 diabetes mellitus	0.000909	0.000971	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	0.000908	0.00097	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NOS3—type 1 diabetes mellitus	0.000892	0.000953	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TNF—type 1 diabetes mellitus	0.00089	0.000951	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—G6PC2—type 1 diabetes mellitus	0.000874	0.000933	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—INS—type 1 diabetes mellitus	0.000852	0.00091	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000832	0.000889	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CD4—type 1 diabetes mellitus	0.000822	0.000878	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ALB—type 1 diabetes mellitus	0.000781	0.000834	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000759	0.000811	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ABCC8—type 1 diabetes mellitus	0.000758	0.000809	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000754	0.000806	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—NOS3—type 1 diabetes mellitus	0.000747	0.000798	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL6—type 1 diabetes mellitus	0.000718	0.000767	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000703	0.000751	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000637	0.00068	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—STAT3—type 1 diabetes mellitus	0.000636	0.00068	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000636	0.000679	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000633	0.000677	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SLC11A1—type 1 diabetes mellitus	0.000632	0.000675	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	0.000615	0.000657	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000605	0.000647	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ITPR3—type 1 diabetes mellitus	0.000604	0.000645	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—HBA1—type 1 diabetes mellitus	0.000599	0.00064	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000599	0.00064	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APOC3—type 1 diabetes mellitus	0.000596	0.000636	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000585	0.000625	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	0.000579	0.000618	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—EGFR—type 1 diabetes mellitus	0.000578	0.000618	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APOC3—type 1 diabetes mellitus	0.000564	0.000603	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IAPP—type 1 diabetes mellitus	0.000564	0.000603	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—B2M—type 1 diabetes mellitus	0.000542	0.000579	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000539	0.000576	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ITPR3—type 1 diabetes mellitus	0.000505	0.00054	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	0.000502	0.000536	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HBA1—type 1 diabetes mellitus	0.000476	0.000508	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOC3—type 1 diabetes mellitus	0.000473	0.000505	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GCG—type 1 diabetes mellitus	0.000466	0.000498	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTT1—type 1 diabetes mellitus	0.000464	0.000496	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS1—type 1 diabetes mellitus	0.000454	0.000485	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IL6—type 1 diabetes mellitus	0.000444	0.000475	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000428	0.000457	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PRKCQ—type 1 diabetes mellitus	0.000425	0.000454	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—VAV1—type 1 diabetes mellitus	0.000413	0.000441	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	0.000406	0.000434	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000397	0.000424	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CAT—type 1 diabetes mellitus	0.000394	0.000421	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	0.000382	0.000408	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GCG—type 1 diabetes mellitus	0.00037	0.000395	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CD86—type 1 diabetes mellitus	0.00036	0.000385	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	0.000335	0.000358	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	0.000331	0.000353	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ERBB3—type 1 diabetes mellitus	0.000325	0.000347	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CCR5—type 1 diabetes mellitus	0.000319	0.000341	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	0.000315	0.000337	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CAT—type 1 diabetes mellitus	0.000313	0.000335	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	0.000313	0.000334	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HLA-A—type 1 diabetes mellitus	0.000311	0.000333	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	0.000307	0.000329	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000283	0.000303	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS2—type 1 diabetes mellitus	0.000271	0.000289	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CD80—type 1 diabetes mellitus	0.000263	0.000281	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—INS—type 1 diabetes mellitus	0.000262	0.00028	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000262	0.000279	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—INS—type 1 diabetes mellitus	0.000248	0.000265	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	0.000245	0.000262	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ALB—type 1 diabetes mellitus	0.00024	0.000256	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—NOS3—type 1 diabetes mellitus	0.00023	0.000245	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TYK2—type 1 diabetes mellitus	0.000222	0.000237	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	0.000221	0.000236	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS3—type 1 diabetes mellitus	0.000218	0.000233	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—INS—type 1 diabetes mellitus	0.000208	0.000222	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	0.000208	0.000222	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	0.000207	0.000222	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	0.000206	0.000221	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	0.000203	0.000217	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CD4—type 1 diabetes mellitus	0.000201	0.000214	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALB—type 1 diabetes mellitus	0.000191	0.000204	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NOS3—type 1 diabetes mellitus	0.000182	0.000195	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	0.000162	0.000173	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—STAT3—type 1 diabetes mellitus	0.000155	0.000166	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EGFR—type 1 diabetes mellitus	0.000141	0.000151	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	0.000138	0.000147	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	0.000137	0.000146	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	0.000126	0.000135	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	0.000121	0.000129	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6—type 1 diabetes mellitus	0.000108	0.000116	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	9.08e-05	9.7e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	8.32e-05	8.89e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	7.96e-05	8.51e-05	CbGpPWpGaD
